Target Protein: HHV8 ORF50
Immunogen Range: 1-40/691
Entrez Gene: 4961526
Swiss Prot: F5HCV3
Source: KLH conjugated synthetic peptide derived from N-terminus of HHV8 ORF50 strain GK18
Purification: Purified by Protein A.
Storage Buffer: Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.
Storage Condition: Store at -20°C for 12 months.
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Cross Reactive Species:
(Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus)
For research use only. Not intended for diagnostic or therapeutic use.